CClinicalTrials.gg
CompletedNCT06392191Updated Jul 1, 2025

Comparison of Bupivacaine Liposomal vs Bupivacaine Combined With Dexamethasone for Postoperative Pain in VATS

An interventional study of Rhombic intercostal nerve block(Received liposomal bupivacaine 93 mg and bupivacaine 25 mg diluted to 20 ml) and Rhombic intercostal nerve block(Receive standard bupivacaine 105 mg diluted to 20 ml with dexamethasone 5 mg.) in Thoracic Surgery, sponsored by Affiliated Hospital of Jiaxing University. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-01.

Sponsored by Affiliated Hospital of Jiaxing University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
148
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study, is to investigate the effectiveness of ultrasound-guided rhombic intercostal nerve block for postoperative pain control in thoracoscopic pulmonary resection with bupivacaine liposomes versus bupivacaine hydrochloride with dexamethasone to assess whether bupivacaine liposomes will produce analgesia superior to bupivacaine hydrochloride with dexamethasone in terms of analgesia effect and duration of analgesia. This study will also evaluate whether liposomal bupivacaine after nerve block improves the quality of postoperative recovery compared to bupivacaine hydrochloride combined with dexamethasone.

Read the detailed description

Approved by the Ethics Committee of Jiaxing No. 1 Hospital (approval number: 2024-KY-226). This study was enrolled prior to patient enrollment in the clinical trial. Written informed consent was obtained from all participants. The study is expected to be conducted from April 2024 through December 2025. This study enrolls 90 elective thoracoscopic lung resection surgery(including wedge resection, segmentectomy, or lobectomy) patients between the ages of 18-80 years, ASA Physical Status I and III, who had no allergic reaction to the study drug.

Basic monitoring such as electrocardiogram, pulse oximetry, and noninvasive blood pressure were arranged preoperatively. The bupivacaine liposome group was treated with bupivacaine liposome 93 mg combined with bupivacaine 25 mg, and the standard control group was treated with bupivacaine hydrochloride 105 mg combined with dexamethasone 5 mg, and both groups were perfused with saline 20 ml. ultrasound-guided rhombic intercostal muscle nerve block was performed for a total of 20 ml. postoperative analgesia was provided using patient-controlled intravenous analgesia (PCIA), and according to the patients weight and baseline condition. Upon arrival of postoperative patients to the ward, if the patient reports significant pain, defined as the numeric rating scale (NRS), score greater than 3, the first step is to administer one press of the analgesic pump. If the pain persists, the pain management protocol will be initiated. Cumulative PCIA consumption at different postoperative time intervals (including 0-24 hours, 24-48 hours, and 48-72 hours). Quality of Recovery Score (QoR-15) at 72 hours postoperatively, If NRS at 6 hours to 3 months, and patient satisfaction were recorded.Pain assessments were performed at the following time points: 0 hours postoperatively (upon tracheal extubation and patient awakening), 0.5 hours, 2 hours, 4 hours, 12 hours, 24 hours, 48 hours, and 72 hours. Pain score follow-up by telephone at the third month.

02

Conditions studied

  • Thoracic Surgery

Keywords

  • Rhombic intercostal nerve block
  • thoracoscopy
  • Bupivacaine liposomes
03

In context

Lead sponsor

Affiliated Hospital of Jiaxing University is the lead sponsor of 16 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

ASA physical status I-III, aged between 18 and 80 years, scheduled for elective thoracoscopic lung resection surgery under general anesthesia with endotracheal intubation (including wedge resection, segmentectomy, or lobectomy) with one or three incisions, expected duration of surgery less than 4 hours, and body mass index (BMI) between 18 and 30 kg/m².

Exclusion criteria

Exclusion Criteria:

  1. trauma or emergency patients;
  2. patients classified as New York Heart Association (NYHA) functional class 3-4;
  3. unstable coronary artery disease patients;
  4. patients with renal system diseases (estimated glomerular filtration rate \<30 mL/min/1.73 m²);
  5. patients with liver system diseases (alanine aminotransferase or aspartate aminotransferase levels exceeding twice the normal value);
  6. patients with coagulation disorders, or those who have not discontinued warfarin or novel anticoagulants (such as rivaroxaban, dabigatran) prior to surgery;
  7. individuals with a history of alcohol abuse or substance dependence within the past two months;
  8. patients with uncontrolled anxiety, schizophrenia, or other psychiatric disorders;
  9. pregnant or planning to become pregnant women;
  10. individuals with a history of allergy to local anesthetics or investigational drugs. Additionally, patients who refuse to sign the informed consent form will also be excluded;
  11. chronic pain syndromes (defined as reflex sympathetic dystrophy or complex regional pain syndrome);
  12. chronic opioid use (longer than 3 months or daily morphine equivalents more than 5 mg/day for 1 month).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
148 participants (actual)

Study arms

  • Other
    Bupivacaine liposomes group

    The nerve block puncture needle was imaged and then entered into the fascial space between the rhomboid and extracostal muscles, and liposomal bupivacaine 93 mg and bupivacaine 25mg diluted to 20 ml were injected into this space.

    Procedure: Rhombic intercostal nerve block(Received liposomal bupivacaine 93 mg and bupivacaine 25 mg diluted to 20 ml)

  • Other
    Standard bupivacaine dexamethasone group

    The nerve block puncture needle was imaged and then entered into the fascial space between the rhomboid and external intercostal muscles, and a mixture of: receive standard bupivacaine 105 mg diluted to 20 ml with dexamethasone 5 mg was injected into this space.

    Procedure: Rhombic intercostal nerve block(Receive standard bupivacaine 105 mg diluted to 20 ml with dexamethasone 5 mg.)

Interventions

  • ProcedureRhombic intercostal nerve block(Received liposomal bupivacaine 93 mg and bupivacaine 25 mg diluted to 20 ml)

    The patient was placed in lateral recumbency and placed medial to the medial border of the scapula in the oblique sagittal plane using a line array ultrasound probe to identify ultrasound landmarks, trapezius, obliques, intercostals, pleura, and lungs, The block needle was then entered in-plane at the T5 level, with the margins retracting on insertion, and the nerve block perforating needle was imaged and then inserted into the fascial gap between the trapezius and the external intercostal muscles. Receive liposomal bupivacaine 93 mg and bupivacaine 25 mg diluted to 20ml.

  • ProcedureRhombic intercostal nerve block(Receive standard bupivacaine 105 mg diluted to 20 ml with dexamethasone 5 mg.)

    The patient was placed in lateral recumbency and placed medial to the medial border of the scapula in the oblique sagittal plane using a line array ultrasound probe to identify ultrasound landmarks, trapezius, obliques, intercostals, pleura, and lungs, The block needle was then entered in-plane at the T5 level, with the margins retracting on insertion, and the nerve block perforating needle was imaged and then inserted into the fascial gap between the trapezius and the external intercostal muscles. A mixture of standard bupivacaine 105 mg diluted to 20 ml with dexamethasone 5 mg was received.

06

What researchers measure

Primary outcomes

  1. Area under the curve

    Area under the curve of the numeric rating scale (NRS) scores at rest

    Time frame: 0-48 hours after surgery

Secondary outcomes

  1. Change in functional pain using Brief Pain Inventory (BPI)

    Compare functional pain using the BPI at baseline, 6 weeks and 3 months. The BPI scale defines pain as follows: Score: 1 - 4 = Mild Pain, Score: 5 - 6 = Moderate Pain, Score: 7 - 10 = Severe Pain.

    Time frame: Preoperative day one, 6 weeks after surgery, 3 months after surgery

  2. Change in Quality of Recovery 15 questionnaire

    15 questions assessing the quality of recovery, rated on a ten-point scale with a total score ranging from 0 (very poor recovery) to 150 (good recovery)

    Time frame: Preoperative day one;Day 1, 2 and 7 after surgery

  3. Change in white blood cell count (WBC)

    Compare the change in postoperative WBC from baseline only for participants that have an overnight hospital stay

    Time frame: Preoperative day one, day 0, day 1 and day 2 after surgery

  4. Length of hospital stay

    The patient post surgical length of stay in the hospital will be compared between treatment groups.

    Time frame: perioperatively

  5. Absolute value of Interleukin 1 beta (IL-1b)

    Absolute value IL-1b at postoperative day 1 only for participants that have an overnight hospital stay

    Time frame: day 1 after surgery

  6. CD3、CD4、CD4/CD8 and CD16+56

    Postoperative day 1 CD3, CD4, CD4/CD8 and CD16+56 only for participants who were hospitalised overnight and pathologically had lung cancer

    Time frame: Preoperative day one,day 1 after surgery

  7. Absolute value of Interleukin 6 (IL-6)

    Absolute value IL-6 at postoperative day 1 only for participants that have an overnight hospital stay

    Time frame: day 1 after surgery

  8. C-reactive protein (CRP)

    Absolute value C-reactive protein at postoperative day 1 only for participants that have an overnight hospital stay

    Time frame: day 1 after surgery

  9. Postoperative chest Pain Score

    Average postoperative chest pain scores for the first two postoperative days using numerical rating scale (NRS) pain score. Score range from 0 (no pain) to 10 (worst pain possible).

    Time frame: Preoperative day one;Day 1 after surgery; Day 2 after surgery; Day 3 after surgery

  10. postoperative complications

    Postoperative complications include arrhythmia, bowel obstruction, atrial fibrillation, and other cardiorespiratory systems.

    Time frame: perioperatively

  11. mean arterial pressure

    Changes in haemodynamics during surgery

    Time frame: Start of surgery to end of surgery

  12. systolic blood pressure

    Changes in haemodynamics during surgery

    Time frame: Start of surgery to end of surgery

  13. diastolic blood pressure

    Changes in haemodynamics during surgery

    Time frame: Start of surgery to end of surgery

  14. heart rate

    Changes in haemodynamics during surgery

    Time frame: Start of surgery to end of surgery

  15. liver function

    Transaminases in biochemical indicators

    Time frame: perioperatively

  16. kidney function

    Creatinine in biochemical indicators

    Time frame: perioperatively

  17. Incidence of remedial analgesia

    Remedial analgesia was given when the patient's numerical analogue score (NRS) was greater than 3 in the postoperative period

    Time frame: perioperatively

07

Study locations

1 site
  • The First Hospital of Jiaxing
    Jiaxing, Zhejiang 942111, China
08

References and documents

Publications

  • Xie Y, Yan D, Shen J. Video-assisted thoracic surgery versus thoracotomy for treatment of patients with pulmonary sequestration: A systematic review and meta-analysis. Asian J Surg. 2023 Aug;46(8):3387-3388. doi: 10.1016/j.asjsur.2023.03.097. Epub 2023 Mar 25. No abstract available. PubMed 36973139 ↗
  • Elsharkawy H, Ince I, Pawa A. Rhomboid intercostal and sub-serratus (RISS) plane block for analgesia after lung transplant. J Clin Anesth. 2019 Sep;56:85-87. doi: 10.1016/j.jclinane.2019.01.042. Epub 2019 Jan 28. No abstract available. PubMed 30703673 ↗
  • Xie L, Xi Y, He X, An M, Jia X, Li Z, Chen T, Zhou Q. Liposomal Bupivacaine vs. Plain Bupivacaine with Dexamethasone for Rhomboid Intercostal Block in the Management of Postoperative Pain After Video-Assisted Thoracoscopic Surgery: A Randomized Non-inferiority Trial. Pain Ther. 2025 Oct;14(5):1513-1530. doi: 10.1007/s40122-025-00763-1. Epub 2025 Aug 4. PubMed 40758210 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06392191
Lead sponsor
Affiliated Hospital of Jiaxing University
Responsible party
Qing-he Zhou (professor, Affiliated Hospital of Jiaxing University) — Principal investigator
First posted
Apr 30, 2024
Start date
Nov 10, 2024
Primary completion
Apr 1, 2025
Completion
May 2, 2025
Last update
Jul 1, 2025

Study contacts

QINGhe ZHOU, professor
principal investigator · deputy chair of board

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion